Our Services
Others
- DFPP
- Shockwave
- IV Drip
A pressure ulcer also called a pressure injury, bedsore, or decubitus ulcer doesn’t form the way most wounds do. There’s no cut, no burn, no outside trauma at all. It’s caused entirely by sustained pressure cutting off blood flow to skin and tissue from the inside out, usually over a bony area like the hip, heel, or tailbone. That mechanism alone makes pressure ulcer treatment a genuinely different clinical problem, and it’s a big part of why stem cell therapy for pressure ulcers is being studied as its own specific application not just lumped in with diabetic or venous wounds and treated the same way. Here’s what actually makes this wound type different, and what the research so far actually shows.
Why Pressure Ulcers Form Differently Than Other Chronic Wounds
It’s a Compression Injury, Not a Trauma Injury
Sustained pressure usually from lying or sitting in one position too long compresses the small blood vessels feeding the skin and tissue underneath. Cut off blood supply for long enough and the tissue starts dying from ischemia, working from the inside toward the surface. By the time a pressure sore actually becomes visible on the skin, the damage underneath is often already worse than it looks which is part of why these wounds catch people off guard.
Who Actually Develops Pressure Injuries
These wounds are especially common in patients with limited mobility people using wheelchairs, bedridden patients, and a large share of people recovering from spinal cord injury, where reduced sensation means the usual warning signs of prolonged pressure often go unnoticed entirely. No pain signal, no reason to shift position, and the damage just keeps building.
Why They’re So Slow to Heal, Even With Good Care
Unlike a surface wound, a pressure ulcer usually involves deep tissue damage before anyone even catches it, and the spots where they form hips, heels, the sacrum don’t have much blood supply to begin with. Put those two things together and you get exactly the kind of wound that resists conventional treatment consistently, which is why regenerative medicine for pressure ulcers has drawn specific research attention rather than being treated as just another chronic wound.
Standard Pressure Ulcer Care and Where It Actually Falls Short
Conventional management centers on pressure relief (repositioning schedules, specialized mattresses and cushions), debridement of dead tissue, and wound dressings to manage the local environment day to day. In more advanced cases, surgical reconstruction flap surgery, specifically becomes the next step. These approaches genuinely work for a lot of patients. But surgical reconstruction carries real costs: extended hospital stays, surgical risk, and a real chance of the wound recurring at the same site down the line. That gap between what standard care can offer and what a severely compromised wound bed actually needs is exactly where stem cell-based wound therapy enters the research conversation.
What Does the Clinical Evidence Actually Show for Pressure Ulcers?
Worth going through this carefully, because pressure ulcer research has produced some genuinely striking numbers and they deserve to be represented accurately, not cherry-picked.
Mesenchymal Stromal Cells: A Systematic Review
A systematic review focused specifically on mesenchymal stromal cell (MSC) therapy for pressure ulcers, pulling from both clinical and preclinical studies, reported some of the more concrete healing data available anywhere in chronic wound research. In one included study, 86.36% of patients 19 out of 22 had fully healed pressure ulcers after a mean treatment period of just 21 days. Average hospital stay dropped from 85 days with conventional surgical treatment down to roughly 43 days with MSC-based pressure ulcer treatment.
Bone Marrow-Derived MSCs Paired With Artificial Dermis
A separate trial combined bone marrow-derived mesenchymal stem cells (BMSCs) with an artificial dermis made from collagen sponge, applied across 20 patients with a mix of pressure ulcers (hip and heel) and lower-leg or foot ulcers. 18 of the 20 patients achieved complete wound healing; the two who didn’t died from unrelated causes during the study, not treatment failure.
BMSCs Specifically in Spinal Cord Injury Patients
Because pressure ulcers show up so often in people with spinal cord injury, one study specifically debrided and treated pressure ulcers with BMSCs in 22 patients with spinal cord injury who had single Type IV (full-thickness) pressure ulcers. The overlap between pressure ulcer research and spinal cord injury research isn’t a coincidence it reflects how frequently these two conditions occur together in real clinical practice.
Engineered MSCs Combined With Adjunct Compounds
More recent, earlier-stage work combining Lcn2-engineered MSCs with an adjunct compound reported a wound repair rate of 95% at 14 days and 100% at 21 days post-treatment in the treatment group significantly outperforming controls in the same study. This is more experimental territory compared to the BMSC research above, but it points to where the field is heading.
How These Mechanisms Actually Apply to Pressure Injuries
Restoring Blood Flow to Ischemic Tissue
Because the core problem in a pressure ulcer is compression-related ischemia, restoring local blood supply matters here more than in almost any other wound type. MSCs support that through angiogenesis releasing VEGF and related signals that push new capillary growth into tissue that’s been starved of oxygen for too long.
Working With Deep, Full-Thickness Damage
Pressure ulcers are usually staged on a Type I–IV classification, with Type IV meaning full-thickness tissue loss reaching muscle, bone, or supporting structures. Almost all of the MSC research referenced above specifically targeted these more severe, full-thickness pressure ulcers not superficial ones which is exactly where conventional treatment struggles the most.
Reducing the Overall Surgical Burden
One of the more practically meaningful findings in this research is the drop in hospital stay when MSC-based treatment replaced or supplemented conventional surgical approaches a real outcome for patient recovery and cost, not just for wound closure on paper.
Structural Support Through Scaffolds
Combining MSCs with an artificial dermis or collagen-based scaffold, rather than delivering cells alone, shows up in more than one study referenced here suggesting structural support genuinely matters for how well these cells engraft and function inside a deep, damaged wound bed.
Delivery Methods Used in Pressure Ulcer Research
- Direct application after debridement dead tissue removed first, then MSCs applied to the cleaned wound bed
- MSC-scaffold combinations cells paired with a collagen sponge or artificial dermis for structural support
- Injection around the wound margin used in some protocols to support healing from the wound edges inward
Who Might Be a Candidate for Stem Cell-Based Pressure Ulcer Treatment?
Based on how the research is actually structured, candidates tend to be patients whose pressure ulcers:
- Are classified as more advanced Type III or Type IV, involving deep or full-thickness tissue loss
- Haven’t responded well enough to standard pressure relief, debridement, and dressing protocols
- Are being considered for surgical reconstruction, where a regenerative option might reduce surgical burden or recovery time
- Occur alongside spinal cord injury or another condition involving prolonged immobility
As always, this comes down to a full medical evaluation wound stage, depth, infection status, and the patient’s overall mobility and health context all shape whether this is the right option. You can review the conditions we treat on our stem cell therapy page, or see real patient outcomes on our results page.
Frequently Asked Questions
How is a pressure ulcer different from a diabetic or venous ulcer? A pressure ulcer is caused by sustained compression cutting off blood flow from the inside out, usually over a bony area. Diabetic ulcers stem from nerve damage and small-vessel disease; venous ulcers stem from failing vein valves. Different root mechanisms entirely, even when the wounds can look similar on the surface.
Why are pressure ulcers so common in spinal cord injury patients? Reduced sensation means the normal warning signs of prolonged pressure the discomfort that would normally prompt someone to shift position often don’t register at all, letting tissue damage build further before anyone catches it.
Can stem cell therapy replace surgical reconstruction for a severe pressure ulcer? Not necessarily “replace” outright but research suggests it may reduce hospital stay and recovery burden compared to surgery alone in some cases. Whether it works as an alternative or a complement to surgery really depends on the individual wound and patient.
Which pressure ulcer stage responds best to stem cell treatment in current research? Most of the clinical data referenced here focuses on more advanced Type III and Type IV pressure ulcers exactly the cases where conventional treatment already struggles most, and where a regenerative approach has the most room to make a real difference.
Is pressure ulcer stem cell treatment available in Thailand? Yes. Thailand’s regenerative medicine sector operates under Thai FDA and Ministry of Public Health oversight, with licensed clinics offering MSC-based treatment for complex, treatment-resistant wounds including advanced pressure injuries.
References
- Mesenchymal Stromal Cell Healing Outcomes in Clinical and Pre-Clinical Models to Treat Pressure Ulcers: A Systematic Review. Journal of Clinical Medicine, 2023. https://doi.org/10.3390/jcm12247545
This article is for informational purposes only and does not constitute medical advice. Stem cell therapy candidacy for pressure ulcers should be determined by a qualified physician following a full medical evaluation, including wound staging and assessment of mobility-related risk factors. Book a consultation with our clinical team to discuss your specific case.